- Home
- QNCX vs WHF Comparison
QNCX vs WHF Comparison
Compare QNCX & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNCX | WHF |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 162.5M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | QNCX | WHF |
|---|---|---|
| Price | $2.81 | $7.08 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 2 |
| Target Price | $7.67 | ★ $7.75 |
| AVG Volume (30 Days) | ★ 698.3K | 235.0K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 24.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $76,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $6.39 |
| 52 Week High | $4.55 | $11.31 |
Technical Indicators
Market Signals| Indicator | QNCX | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 47.90 |
| Support Level | $3.18 | $6.84 |
| Resistance Level | $3.38 | $7.23 |
| Average True Range (ATR) | 0.27 | 0.19 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 6.51 | 51.52 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.